<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(3)</volume><submitter>Barco G</submitter><pubmed_abstract>The possible future emergence of new SARS-CoV-2 virus variants pushes the development of new chemoprophylaxis protocols complementary to the unspecific and specific immune-prophylaxis measures currently used. The SARS-CoV-2 virus is particularly sensitive to oxidation, due to the relevant positive electrical charge of its spike protein used as a ligand for target cells. The present study evaluated the safety and efficacy of a new oxidant preparation, liquid hyperoxygen (IOL), to neutralize the SARS-CoV-2 virus. IOL was incubated with throat swabs containing a human-type virus. The samples were then incubated with cells expressing the ACE2 receptor and, therefore, very sensitive to SARS-CoV-2 infection. The ability to neutralize SARS-CoV-2 was determined by assessing the amount of viral nuc</pubmed_abstract><journal>Pathogens (Basel, Switzerland)</journal><pagination>244</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10974922</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Indoor Inactivation of SARS-CoV-2 Virus by Liquid Hyperoxygen.</pubmed_title><pmcid>PMC10974922</pmcid><pubmed_authors>Barco G</pubmed_authors><pubmed_authors>Prati U</pubmed_authors><pubmed_authors>Khalid Z</pubmed_authors><pubmed_authors>Pulliero A</pubmed_authors><pubmed_authors>Angelinetta C</pubmed_authors><pubmed_authors>Izzotti A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Indoor Inactivation of SARS-CoV-2 Virus by Liquid Hyperoxygen.</name><description>The possible future emergence of new SARS-CoV-2 virus variants pushes the development of new chemoprophylaxis protocols complementary to the unspecific and specific immune-prophylaxis measures currently used. The SARS-CoV-2 virus is particularly sensitive to oxidation, due to the relevant positive electrical charge of its spike protein used as a ligand for target cells. The present study evaluated the safety and efficacy of a new oxidant preparation, liquid hyperoxygen (IOL), to neutralize the SARS-CoV-2 virus. IOL was incubated with throat swabs containing a human-type virus. The samples were then incubated with cells expressing the ACE2 receptor and, therefore, very sensitive to SARS-CoV-2 infection. The ability to neutralize SARS-CoV-2 was determined by assessing the amount of viral nuc</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-22T21:31:10.876Z</modification><creation>2025-04-06T03:34:20.081Z</creation></dates><accession>S-EPMC10974922</accession><cross_references><pubmed>38535587</pubmed><doi>10.3390/pathogens13030244</doi></cross_references></HashMap>